Symbicort SMART Satisfaction From Patient Perspective 2009
NCT00946452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 205
Last updated 2010-03-18
Summary
To characterize the level of asthma control and patient satisfaction amongst diagnosed asthma sufferers who are currently receiving Symbicort Maintenance and Reliever Therapy (SMART) in Malaysia.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Liam Chong Kin, Professor · UMMC
Eligibility
- Min Age
- 18 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- Malaysia
Study Locations
More Related Trials
-
Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
NCT00573222 ·Status: COMPLETED
-
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
NCT00785733 ·Status: COMPLETED
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT00784953 ·Status: COMPLETED
-
Study to Investigate the Efficacy of Symbicort® SMART.
NCT00839800 ·Status: COMPLETED ·Phase: PHASE3
-
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
NCT00532922 ·Status: COMPLETED
-
Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)
NCT00937066 ·Status: COMPLETED
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT01647646 ·Status: COMPLETED ·Phase: PHASE4
-
Local Phase 4 Pan-European SMART Study
NCT00463866 ·Status: COMPLETED ·Phase: PHASE4
-
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice
NCT00505388 ·Status: COMPLETED
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler
NCT00812682 ·Status: COMPLETED
-
An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients
NCT03924635 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Asthma Control Level in Primary Care Setting in Malaysia
NCT03804632 ·Status: COMPLETED
-
Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma
NCT01099722 ·Status: COMPLETED ·Phase: PHASE3
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
Gemini Symbicort pMDI
NCT00646516 ·Status: COMPLETED ·Phase: PHASE3
-
Atlantis Symbicort
NCT00646594 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy
NCT01711840 ·Status: COMPLETED
-
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients
NCT00837967 ·Status: COMPLETED ·Phase: PHASE3
-
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
NCT01360021 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART
NCT00503061 ·Status: COMPLETED
-
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255 ·Status: COMPLETED ·Phase: PHASE3
-
SIM0718 Treatment of Asthma Clinical Study
NCT06488755 ·Status: RECRUITING ·Phase: PHASE3
-
A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.
NCT00858286 ·Status: COMPLETED ·Phase: PHASE4